Eli Lilly Announces New Plant in Pennsylvania as Part of Expansion

Eli Lilly announces new plant in Pennsylvania as part of expansion

The company said the new plant will make injectable drugs and devices, including producing weight-loss drug retatrutide, which is still being studied and not available for public use.

Eli Lilly chooses rural Pennsylvania for $3.5B weight-loss drug production

The development is the fourth announced by the pharmaceutical giant since September as competitors look to reshore operations and upgrade their facilities in the U.S.

Eli Lilly and Company $LLY Shares Sold by AGF Management Ltd.

AGF Management Ltd. lowered its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 63.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 116,034 shares of the company’s stock after selling 199,667 shares during the quarter. AGF Management Ltd.’s holdings in Eli Lilly and Company were worth $88,534,000 at the end of the most recent quarter. Other instituti…

Lilly names Pennsylvania site for its latest US facility

Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US - a $3.5bn facility in Pennsylvania.

Eli Lilly selects Pennsylvania for $3.5bn obesity drugs manufacturing site - Pharmaceutical Technology

Historically a steel production hub, Lehigh Valley will now help manufacture Lilly’s weight loss drug hopeful retatrutide.

Eli Lilly Building Billion Dollar Plant In PA

More economic growth for the Commonwealth.  Eli Lilly is planning to build a multi-billion-dollar manufacturing plant in Lehigh Valley, Pennsylvania.  It will be the fourth facility in a string of new planned U.S. investments by the Indiana-based pharmaceutical giant over the last year.  According to Eli Lilly, the plant will help make its next-generation obesity drugs, including a drug that has shown the highest weight loss of any treatment see…